Selected Reading
- DeSoyza N et al: Acebutolol therapy for ventricular arrhythmias: A randomized, placebo-controlled double-blind multicenter study. Circulation 65: 1129, 1982
- Kreeger RW, Hammill SC: New antiarrhythmic drugs: Tocainide, mexiletine, flecainide, encainide, amiodarone. Mayo Clin Proc 62: 1033, 1987
- Kutalek SP. Morganroth J. Horowitz LN: Tocainide: A new oral antiar-rhythmic agent. Ann Intern Med 103: 387, 1985
- Morganroth J. Nestico FF, Horowitz LN: A review of the uses and limitations of tocainide: A class IB antiarrhythmic agent. Am Heart J 110: 856, 1985
- Podrid PJ, Lown B: Propafenone: A new agent for ventricular arrhythmia J Am Coll Cardiol 4: 117. 1984
- Roden DM. Woosley RL: Drug therapy: Flecainide. N Engl J Med 315: 36, 1986
- Naccarelli GV et al: Encainide: A review of its electrophysiology, pharmacology and clinical efficacy. Clin Prog Electrophysiol Pacing 3: 268, 1985
- Naccarelli GV et al: Amiodarone: Pharmacology and antiarrhythmic and adverse effects. Pharmacotherapy 5: 298. 1985
- Woosley RL, Shand DG: Pharmacokinetics of antiarrhythmic drugs. Am J Cardiol 41: 986. 1978